Preparation and In Vitro Antibacterial Activity of 9-0-Glycosyloxime Derivatives of Erythromycin A, a New Class of Macrolide Antibiotics
Cyrille Grandjean* and Gabor Lukacs Institut de Chimie des Substances Naturelles du CNRS, 91 198 Gif sur Yvette Cedex, France (Received for publication April 30, 1996) 9-0-Glycosyloxime derivatives of erythromycin A have been synthesized and their in vitro antibacterial activity comparedwith that oferythromycin A (1) . This newclass ofmacrolide antibiotics showedreduced antibacterial spectrum. However,somederivatives were as or moreactive than erythromycin A (1) against strains, responsible for respiratory track infections, such as Haemophilus injiuenzae, Moraxella catarrhalis or Streptococcus pneumoniae.
The therapeutic utility of erythromycin A (1) has never been refuted for over four decades and this antibiotic remains largely used in clinics1>2). However, the use of erythromycin A (1) suffers from limitations. Of particular importance is the poor resorption of this orally administered drug due to its instability in the gastric juice: at low pH, erythromycin A (1) is, indeed, transformed into inactive metabolites via acetalic intermediates3). Its hepatotoxicity is a second limiting factor:
erythromycin A (1) has been shown to induce and inactivate glucocorticoid responsive isoenzymes4). The production of a suicide-type inhibitory complex was thought to proceed via 7V-demethylation followed by oxidation into nitrosoalkane reactive species of the Ndimethylamino group5). As a tertiary amine is essential for the binding of macrolide antibiotics with their ribosomal target within the bacteria6), the hepatotoxicity can only be reduced by (a) increasing the amine pKa to favour the proportion of the protonated form at physiological pH7) (b) increasing the steric hindrance around the 7V-dimethylamino group8) (c) inducing conformational changes9) (d) diminishing the hydrophobicity (e.g. comparative study of hepatotoxicity of oleandomycin and troleandomycin8)).
Only little attention has been payed to investigate the structure-activity relationship on hepatotoxicity. However, considerable efforts were devoted to circumvent the acidic degradation pathway of erythromycin A. These investigations led to the discovery of several hemisynthetic drugs3), among which has emerged roxithromycin10) (2), a 9-ether oxime derivative. Focusing on hydrophobicity, we planned to introduce extra hydroxy groups on erythromycin A (1). Linkage of carbohydrates to (E)-9-erythromycin A oxime OCT. 1996 (3) was thought to fulfil our goal while not considerably affecting tissue penetration, an essential character of macrolide antibiotics. In this paper, the deprotection step of recently reported1 1\ fully protected (9-glycosyloxime derivatives of erythromycin A and their in vitro antibacterial activity evaluation are described.
Chemistry
Compounds4~ll were obtained regiospecifically via All reactions were carried out in the presence of a catalytic amount of Pd/C 10%w/w. conditions12). Treatment of compound 4 with ammoniumformate and formic acid in the presence ofpalladium on charcoal 10% w/w (Pd/C 10% w/w) in 'refluxed MeOHafforded compound 12 in 40% yield together with a substantial amount (35%) of starting material and some degradation products (Table 1 , entry a). Obviously, the benzylidene acetal group was stable under these conditions. Thus, we turned to classical hydrogenolysis. Reaction of compound 4 under atmospheric pressure of hydrogen in the presence of a catalytic amount of Pd/C 10% w/w in EtOH allowed the desired cleavage of both the benzyl and benzylidene groups. Unfortunately, the reaction was accompanied by the loss of the cladinose moiety and compound 13 was obtained as a sole product in excellent yield (Table 1 , entry b). This unexpected loss of cladinose probably resulted from the acidification of the reaction mixture. To prevent its formation, the reaction was run in the presence of sodium acetate (Table  1 , entry c). However, these conditions afforded the above mentioned compound 12 in rather improved yield.
Slightly lowering the pH of the reaction medium was thought to diminish the stability of the benzylidene acetal ring. Thus, deprotection was attempted in an acetic acid/sodium acetate buffer in a mixture of according to the literature14) ( A (1) . Surprisingly, the observed activity does not simply derive from the creation of an hydrophilic region but depends on more subtile structural changes such as the anomeric configuration of the newly introduced carbohydrate, the binding site on this carbohydrate and even on the nature {i.e. axial or equatorial) of this bond.
For example, compound 21 is about two to four fold more active than compound 22 against the selected strains. These two compounds only differ from the carbon ofthe glucose moietyat which the oxime is bond(at the C-6 position for compound22 andat the C-4 position for compound22). Thedifference of activity of compounds 14 and 17 or18 and 22 is even morestriking andis only due tothe orientation of the oximiclinkage (either axial for compounds 14 and18 or equatorial for compounds 17 and 22 .9 (C-6""),
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.3 (C-6"' ), 69.1 (C-2"' ), 69A (C-5' "), 71.6 (C-3' "), 73.9 
